These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25664525)

  • 1. Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis.
    Strickland JC; Rush CR; Stoops WW
    J Exp Anal Behav; 2015 Mar; 103(2):361-74. PubMed ID: 25664525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment.
    Stoops WW; Lofwall MR; Nuzzo PA; Craig LB; Siegel AJ; Walsh SL
    Psychopharmacology (Berl); 2012 Oct; 223(4):427-38. PubMed ID: 22623016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors.
    Suzuki T; Mori T; Tsuji M; Misawa M; Nagase H
    Eur J Pharmacol; 1995 Sep; 284(1-2):195-8. PubMed ID: 8549626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of tramadol on morphine discriminative behavior in rats.
    Ren YH; Zheng JW
    Acta Pharmacol Sin; 2000 Oct; 21(10):924-6. PubMed ID: 11501045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
    Negus SS; Gatch MB; Mello NK
    Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users.
    Stoops WW; Glaser PE; Rush CR
    Psychopharmacology (Berl); 2013 Jul; 228(2):255-62. PubMed ID: 23430163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.
    Carroll CP; Walsh SL; Bigelow GE; Strain EC; Preston KL
    Exp Clin Psychopharmacol; 2006 May; 14(2):109-20. PubMed ID: 16756415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of tramadol in humans.
    Duke AN; Bigelow GE; Lanier RK; Strain EC
    J Pharmacol Exp Ther; 2011 Jul; 338(1):255-62. PubMed ID: 21467190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with hydromorphone, a mu-opioid agonist, does not alter the acute behavioral and physiological effects of ethanol in humans.
    Rush CR
    Alcohol Clin Exp Res; 2001 Jan; 25(1):9-17. PubMed ID: 11198720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone.
    Bertalmio AJ; Woods JH
    Psychopharmacology (Berl); 1992; 106(2):189-94. PubMed ID: 1347952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
    Preston KL; Bigelow GE; Bickel W; Liebson IA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose.
    Preston KL; Bigelow GE
    Behav Pharmacol; 1998 Nov; 9(7):533-43. PubMed ID: 9862079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a novel fentanyl derivative on drug discrimination and learning in rhesus monkeys.
    Gerak LR; Moerschbaecher JM; Bagley JR; Brockunier LL; France CP
    Pharmacol Biochem Behav; 1999 Oct; 64(2):367-71. PubMed ID: 10515315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.